Abstract: The invention relates to a gene transfer-based method to protect a subject from Sjogren's syndrome. The method comprises administering to the subject an AAV virion comprising an AAV vector that encodes aquaporin-1 (AQP-1) protein. Also provided are AQP-1 proteins and nucleic acid molecules that encode such proteins. Also provided are AAV vectors and AAV virions that encode an AQP-1 protein.
Type:
Grant
Filed:
August 30, 2013
Date of Patent:
January 1, 2019
Assignee:
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT. OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH
Abstract: Disclosed herein are methods of detecting tumors, monitoring cancer therapy, and selectively inhibiting the proliferation and/or killing of cancer cells utilizing a papilloma pseudovirus or a papilloma virus-like particle (VLP).
Type:
Grant
Filed:
May 1, 2008
Date of Patent:
March 12, 2013
Assignee:
The United States of America as represented by the Secretary, Dept. of Health and Human Services National Institutes of Health
Inventors:
Jeff Roberts, Douglas R. Lowy, John T. Schiller